561 related articles for article (PubMed ID: 34870920)
21. Gut-oriented disease modifying therapy for Parkinson's disease.
Lin CH; Lai HC; Wu MS
J Formos Med Assoc; 2023 Jan; 122(1):9-18. PubMed ID: 36182642
[TBL] [Abstract][Full Text] [Related]
22. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
[TBL] [Abstract][Full Text] [Related]
23. Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson's Disease.
Perez-Pardo P; Hartog M; Garssen J; Kraneveld AD
Curr Behav Neurosci Rep; 2017; 4(4):361-368. PubMed ID: 29201595
[TBL] [Abstract][Full Text] [Related]
24. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
Kim N; Yun M; Oh YJ; Choi HJ
J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
[TBL] [Abstract][Full Text] [Related]
25. Human gut microbiota and Parkinson's disease.
Pant A; Bisht KS; Aggarwal S; Maiti TK
Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
[TBL] [Abstract][Full Text] [Related]
26. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
27. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
Raj K; Singh S; Chib S; Mallan S
Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
[TBL] [Abstract][Full Text] [Related]
28. The gut in Parkinson's disease: Bottom-up, top-down, or neither?
Leclair-Visonneau L; Neunlist M; Derkinderen P; Lebouvier T
Neurogastroenterol Motil; 2020 Jan; 32(1):e13777. PubMed ID: 31854093
[TBL] [Abstract][Full Text] [Related]
29. New hope for Parkinson's disease treatment: Targeting gut microbiota.
Fan HX; Sheng S; Zhang F
CNS Neurosci Ther; 2022 Nov; 28(11):1675-1688. PubMed ID: 35822696
[TBL] [Abstract][Full Text] [Related]
30. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
Campos-Acuña J; Elgueta D; Pacheco R
Front Immunol; 2019; 10():239. PubMed ID: 30828335
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.
Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S
Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503
[TBL] [Abstract][Full Text] [Related]
33. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
[TBL] [Abstract][Full Text] [Related]
34. Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease.
Liu J; Xu F; Nie Z; Shao L
Front Cell Infect Microbiol; 2020; 10():570658. PubMed ID: 33194809
[TBL] [Abstract][Full Text] [Related]
35. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms.
Felice VD; Quigley EM; Sullivan AM; O'Keeffe GW; O'Mahony SM
Parkinsonism Relat Disord; 2016 Jun; 27():1-8. PubMed ID: 27013171
[TBL] [Abstract][Full Text] [Related]
36. Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies.
Zhang X; Tang B; Guo J
Transl Neurodegener; 2023 Dec; 12(1):59. PubMed ID: 38098067
[TBL] [Abstract][Full Text] [Related]
37. Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis.
Claudino Dos Santos JC; Lima MPP; Brito GAC; Viana GSB
Ageing Res Rev; 2023 Feb; 84():101812. PubMed ID: 36455790
[TBL] [Abstract][Full Text] [Related]
38. Interactions between the microbiota and enteric nervous system during gut-brain disorders.
Fried S; Wemelle E; Cani PD; Knauf C
Neuropharmacology; 2021 Oct; 197():108721. PubMed ID: 34274348
[TBL] [Abstract][Full Text] [Related]
39. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies.
Perez-Pardo P; Kliest T; Dodiya HB; Broersen LM; Garssen J; Keshavarzian A; Kraneveld AD
Eur J Pharmacol; 2017 Dec; 817():86-95. PubMed ID: 28549787
[TBL] [Abstract][Full Text] [Related]
40. Parkinson's disease: Are gut microbes involved?
Omotosho AO; Tajudeen YA; Oladipo HJ; Yusuff SI; AbdulKadir M; Muili AO; Egbewande OM; Yusuf RO; Faniran ZO; Afolabi AO; El-Sherbini MS
Brain Behav; 2023 Aug; 13(8):e3130. PubMed ID: 37340511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
